NRC Health (NRC)
NASDAQ: NRCHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
NRC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $533.93M
- P/E (TTM)
- 93.19
- Forward P/E
- 23.74
- EPS (TTM)
- $0.27
- Dividend yield
- 2.54% ($0.64)
- Ex-dividend date
- Sep 25, 2026
- 52-week range
- 11.74 – 27.60
- Day range
- 24.38 – 25.34
- Volume / Avg
- 88.91K / 110.81K
- Beta
- —
- Shares outstanding
- 21.22M
52-week range
NRC stock today
Shares of NRC Health (NRC) finished higher on Nov 20 at $25.16, a gain of 0.68% or $0.17 per share, versus the S&P 500's 3.70% decline. Shares are 8.8% below their 52-week high of $27.60, set on Nov 12, 2026 and 114.4% above the 52-week low of $11.74, near the top of the past year's range. NRC is up 34.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 42.5%.
NRC Health trades at 93.2x its trailing twelve-month earnings per share of $0.27. Its forward P/E of 23.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. NRC Health pays an annual dividend of $0.64 per share, a 2.54% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About NRC Health
Company profileNRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage.
- Sector
- Health Care
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- CEO
- Mr. Trent S. Green
- Headquarters
- Lincoln, NE
- Employees
- 357
- Website
- nrchealth.com
Financial highlights
Full financialsIn fiscal 2025, NRC Health generated $137.4 million in revenue, down 4.0% from fiscal 2024, its first annual decline since 2024. Net income was $11.6 million (-53.2% year over year), for a net margin of 8.4% versus a median of 21.0% in the prior 5 years. Operating margin was 16.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $137.39M | $143.06M | $148.58M | $151.57M | $147.95M |
| Growth | -3.96% | -3.72% | -1.97% | +2.44% | +11.01% |
| Net income | $11.60M | $24.78M | $30.97M | $31.80M | $37.47M |
| EPS (diluted) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 |
Analyst forecast
ForecastConsensus (1 analysts)
none
Avg. price target
$27.00+7.31%
- Strong buy 1
- Buy 0
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 27, 2026
- EPS actual vs est.
- $0.21 vs $0.21
- Surprise
- 0.00%
Dividends
Dividend history- Annual dividend
- $0.64
- Dividend yield
- 2.54%
- Last payment
- $0.16
- Ex-dividend date
- Sep 25, 2026
NRC news
All NRC news- NRC Health: 3 Key Takeaways for Long-Term InvestorsNasdaq
- NRC Health (NRC) Q3 2026 Earnings Call TranscriptNasdaqNRC, BRK.B
- National Research Corporation Reports Third Quarter 2026 Revenue of $38.4 millionNasdaqNRC, LEN.B
- NRC Health Announces Third Quarter 2026 ResultsBusiness Wire
- NRC Health Trades at a Discount: Should You Buy, Sell or Hold?NasdaqNRC, IRM
NRC Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OABIOmniAb Inc. | 4.66 | -7.36% | $679.71M | vs NRC |
| MXCTMaxCyte Inc. | 1.37 | +7.03% | $141.45M | vs NRC |
| ONMDOneMedNet Corp Class A | 4.70 | +4.21% | $29.15M | vs NRC |
| BIAFbioAffinity Technologies Inc. | 1.65 | -10.81% | $3.00M | vs NRC |
| ISPCiSpecimen Inc. | 0.4563 | -13.58% | $2.64M | vs NRC |
| ABSIAbsci Corporation | 7.51 | -7.97% | $1.30B | vs NRC |
| ICLRICON plc | 186.71 | -1.92% | $13.99B | vs NRC |
| CRLCharles River Laboratories International Inc. | 314.32 | -4.15% | $15.06B | vs NRC |
Indexes, lists and sector
NRC Health stock FAQ
What is NRC Health's stock price today?
NRC last traded at $25.16 as of Nov 20, 4:00 PM EST, up 0.68% on the day. Prices are delayed at least 15 minutes.
Does NRC Health pay a dividend?
Yes. NRC Health pays $0.64 per share annually, a 2.54% yield. The most recent dividend of $0.16 had an ex-dividend date of Sep 25, 2026.
What is NRC's P/E ratio?
NRC trades at a trailing P/E ratio of 93.19 and a forward P/E of 23.74.
Who is NRC Health's CEO?
Mr. Trent S. Green is the chief executive officer of NRC Health, which has about 357 employees.
What is the NRC 52-week high?
The 52-week high for NRC is $27.60 and the 52-week low is $11.74. The stock is currently 8.8% below its high.